These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20624773)

  • 1. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
    Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
    Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
    Saito T; Matsunaga A; Oikawa S
    Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Li LS
    J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy.
    Hagiwara M; Yamagata K; Matsunaga T; Arakawa Y; Usui J; Shimizu Y; Aita K; Nagata M; Koyama A; Zhang B; Mastunaga A; Saku K; Saito T
    Nephrol Dial Transplant; 2008 Jan; 23(1):381-4. PubMed ID: 17967799
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
    Sam R; Wu H; Yue L; Mazzone T; Schwartz MM; Arruda JA; Dunea G; Singh AK
    Am J Kidney Dis; 2006 Mar; 47(3):539-48. PubMed ID: 16490634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of a novel apolipoprotein E variant, ApoE Osaka/Kurashiki, in lipoprotein glomerulopathy.
    Saito T; Matsunaga A
    J Atheroscler Thromb; 2011; 18(6):542-3. PubMed ID: 21670560
    [No Abstract]   [Full Text] [Related]  

  • 8. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].
    Han HL; Lin S; Sun LS; Zhang P; Zhai DP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients].
    Chen YQ; Zhang H; Zhu SL; Zou WZ; Wang M; Liu ZS; Wang HY
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):774-7. PubMed ID: 12899757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein glomerulopathy].
    Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():353-60. PubMed ID: 11347095
    [No Abstract]   [Full Text] [Related]  

  • 11. A rare case of lipoprotein glomerulopathy in a white man: an emerging entity in Asia, rare in the white population.
    Boumendjel R; Papari M; Gonzalez M
    Arch Pathol Lab Med; 2010 Feb; 134(2):279-82. PubMed ID: 20121619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
    Wu H; Yang Y; Hu Z
    J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports.
    Wang R; Zhao C; Chen W; Liu Z; Xie F
    J Med Case Rep; 2022 Feb; 16(1):78. PubMed ID: 35193676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
    Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
    Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein glomerulopathy.
    Tsimihodimos V; Elisaf M
    Curr Opin Lipidol; 2011 Aug; 22(4):262-9. PubMed ID: 21464714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.
    Mitani A; Ishigami M; Watase K; Minakata T; Yamamura T
    J Atheroscler Thromb; 2011; 18(6):531-5. PubMed ID: 21325775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.
    Toyota K; Hashimoto T; Ogino D; Matsunaga A; Ito M; Masakane I; Degawa N; Sato H; Shirai S; Umetsu K; Tamiya G; Saito T; Hayasaka K
    J Hum Genet; 2013 May; 58(5):254-8. PubMed ID: 23407349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological analyses of lipoprotein glomerulopathy].
    Hu ZX; Zhang XH; Sha ZH; Yang LC; Huang SM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):442-4. PubMed ID: 15181857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoprotein glomerulopathy].
    Saito T
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():112-6. PubMed ID: 17899837
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of apolipoprotein E polymorphism with lipoprotein glomerulopathy. Report of 2 cases with a new genotype and comparison of the relative frequencies of apolipoprotein E isoforms in lipoprotein glomerulopathy and in the general population.
    Yang AH; Ng YY; Tarng DC; Chen JY; Shiao MS; Kao JT
    Nephron; 1998; 78(3):266-70. PubMed ID: 9546684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.